CARTITUDE-1: Phase 1b/2 study of ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T cell therapy, in relapsed/refractory multiple myeloma Meeting Abstract


Authors: Madduri, D.; Berdeja, J. G.; Usmani, S. Z.; Jakubowiak, A.; Agha, M.; Cohen, A. D.; Stewart, A. K.; Hari, P.; Htut, M.; O'Donnell, E.; Munshi, N. C.; Avigan, D. E.; Deol, A.; Lesokhin, A. M.; Singh, I.; Zudaire, E.; Yeh, T. M.; Allred, A. J.; Olyslager, Y.; Banerjee, A.; Goldberg, J. D.; Schecter, J. M.; Jackson, C. C.; Deraedt, W.; Zhuang, S. H.; Infante, J. R.; Geng, D.; Wu, X.; Carrasco, M. J.; Akram, M.; Hossain, F.; Rizvi, S.; Fan, F.; Jagannath, S.; Lin, Y.; Martin, T. 3rd
Abstract Title: CARTITUDE-1: Phase 1b/2 study of ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T cell therapy, in relapsed/refractory multiple myeloma
Meeting Title: 62nd Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 136
Issue: Suppl. 1
Meeting Dates: 2020 Dec 5-8
Meeting Location: Virtual
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2020-11-05
Language: English
ACCESSION: WOS:000607547202217
DOI: 10.1182/blood-2020-136307
PROVIDER: wos
Notes: Meeting Abstract: 22 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Meyer Lesokhin
    363 Lesokhin